SCHEMBL23213368

SCHEMBL23213368

OCCC(CCO)c1cc(F)c(F)cc1O.OCCC(CCO)c1cc(F)c(F)cc1OCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.38
PTPN1 P18031 2/20 0.38
NPC1 O15118 1/20 0.37
PTGER1 P34995 1/20 0.37
S1PR5 Q9H228 1/20 0.37
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
SGMS2 Q8NHU3 1/20 0.36
MCL1 Q07820 1/20 0.35
KDM1A O60341 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN6 P29350 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGS2 P35354 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23295193 0.94 MRGPRX4 (0.41) MRGPRX4NPC1PTGER1S1PR5CYP4F2
SCHEMBL29619690 0.94 MRGPRX4 (0.41) MRGPRX4NPC1PTGER1S1PR5CYP4F2
SCHEMBL29619704 0.79 SLC6A9 (0.45) MRGPRX4NPC1PTGER1S1PR5LMNA
SCHEMBL23209843 0.79 SLC6A9 (0.42) MRGPRX4NPC1PTGER1CYP4F2CYP4A11
SCHEMBL29619701 0.79 SLC6A9 (0.42) MRGPRX4NPC1PTGER1CYP4F2CYP4A11
SCHEMBL23210176 0.79 SLC6A9 (0.45) MRGPRX4NPC1PTGER1S1PR5LMNA
SCHEMBL23213252 0.78 ADRA2A (0.38)
SCHEMBL29619688 0.78 ADRA2A (0.38)
SCHEMBL31357720 0.77 LTA4H (0.40) MRGPRX4NPC1PTGER1S1PR5CYP4F2
SCHEMBL23212925 0.77 SLC6A9 (0.43) MRGPRX4NPC1PTGER1LMNALIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed